Treatment with a low-dose triple-combination pill (GMRx2) reduced the risk of recurrent stroke by 39% in patients with previous brain bleeding and high blood pressure. The TRIDENT trial, published in NEJM, found that the single-pill regimen prevented one stroke for every 35 patients.
·
0 reactions
·
0 comments
·
7 views
Original article
Reddit Science
Anonymous · no account needed